Results 281 to 290 of about 1,045,421 (416)

Sonographic findings of biliary tract disease [PDF]

, 1983
Duck Soo Chung, Jin Seok Kim, Bomin Kim, S W Kim, C K Lee   +4 more
openalex   +1 more source

A Large‐Scale Retrospective Study of Serum Des‐Gamma‐Carboxy Prothrombin as a Diagnostic Marker of HCC: Effect of Liver Function on Specificity

Journal of Clinical Laboratory Analysis, EarlyView.
Serum DCP may serve as an optimal biomarker for the diagnosis of HCC, but its accuracy appears to be influenced by liver function. The serum DCP may also serve as a biomarker for liver resection and interventional therapy of HCC, but is not promising for systemic treatment. ABSTRACT Background This retrospective multicenter study is aimed at evaluating
Hongying Bu, Weijia Luo, Wenli Tao, Chen Dong, Meifang Wang, Xu Ye, Xi Zeng, Boqing Wang, Chang Liu, Qi Yu, Deliang Cao, Hongyu Deng, Yuemin Nan   +12 more
wiley   +1 more source

The expression and related biological behavior of the anillin-actin-binding-protein gene in hepatocellular-carcinoma cells

Asian Journal of Surgery, 2023
Di Zhang, Hui Jiao Zhang, Guo Sheng Wang, Jian Guo Li   +3 more
doaj  

Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible? [PDF]

World J Gastroenterol
Chen JQ, Lan X.
europepmc   +1 more source

Liver and Biliary Tract Disease in Children [PDF]

, 1980
J. F T Glasgow
openalex   +1 more source

Biliary Tract Injuries [PDF]

, 2018
Zelić, Marko, Lekić, Veronika, Bazdulj, Edo, Hauser, Goran   +3 more
openaire   +3 more sources

Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic‐Associated Fatty Liver Disease

The Journal of Clinical Pharmacology, EarlyView.
Abstract Fenofibrate is contraindicated in patients with advanced hepatic fibrosis due to limited clinical data. We evaluated the pharmacokinetics and safety of fenofibrate in participants with mild hepatic impairment (phase 1 study) or advanced fibrosis due to metabolic‐associated fatty liver disease (MAFLD; phase 2a study).
Islam R. Younis, Elijah J. Weber, Cara Nelson, Ann R. Qin, Timothy R. Watkins, Ahmed A. Othman   +5 more
wiley   +1 more source

Comparison of monotherapy and combination therapy for older patients with advanced biliary tract cancer: a retrospective study. [PDF]

BMC Cancer
Oishi R, Kobayashi S, Nagashima S, Fukushima T, Tezuka S, Morimoto M, Ueno M, Maeda S.   +7 more
europepmc   +1 more source

Carcinoma arising in a congenitally dilated biliary tract

, 1978
Yoshihieo Kagawa, Sadao Kashihara, Shinji Kuramoto, Shunzo Maetani   +3 more
openalex   +1 more source

Prognostic roles nutritional index in patients with resectable and advanced biliary tract cancers. [PDF]

World J Gastroenterol
Zeng D, Wen NY, Wang YQ, Cheng NS, Li B.
europepmc   +1 more source